Your browser doesn't support javascript.
loading
Integrated investigation of the prognostic role of HLA LOH in advanced lung cancer patients with immunotherapy.
Zhang, Xiaotao; Tang, Hongzhen; Luo, Haitao; Lu, Huiping; Pan, Chaohu; Yu, Haiming; Zhang, Linlin; Guan, Yaping; Yu, Lan; Chu, Huili; Chen, Jun; Wang, Jun.
Afiliação
  • Zhang X; Affiliated Qingdao Central Hospital of Qingdao University, Qingdao, China.
  • Tang H; YuceBio Technology Co., Ltd., Shenzhen, China.
  • Luo H; YuceBio Technology Co., Ltd., Shenzhen, China.
  • Lu H; YuceBio Technology Co., Ltd., Shenzhen, China.
  • Pan C; YuceBio Technology Co., Ltd., Shenzhen, China.
  • Yu H; Affiliated Qingdao Central Hospital of Qingdao University, Qingdao, China.
  • Zhang L; Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, China.
  • Guan Y; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Yu L; Shandong Lung Cancer Institute, Jinan, China.
  • Chu H; Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Jinan, China.
  • Chen J; Affiliated Qingdao Central Hospital of Qingdao University, Qingdao, China.
  • Wang J; Department of Oncology, The 960th Hospital of PLA, Jinan, China.
Front Genet ; 13: 1066636, 2022.
Article em En | MEDLINE | ID: mdl-36531232
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article